Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2007-07-19
2010-10-12
Nickol, Gary B. (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S325000, C435S368000, C514S114000
Reexamination Certificate
active
07811822
ABSTRACT:
The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via S1P or LPA signaling. These methods are useful for reducing at least one symptom of the disorder.
REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4692147 (1987-09-01), Duggan
patent: 5011678 (1991-04-01), Wang et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5254330 (1993-10-01), Ganderton et al.
patent: 5670477 (1997-09-01), Poduslo et al.
patent: 5712262 (1998-01-01), Spiegel
patent: 5766897 (1998-06-01), Braxton
patent: 5832932 (1998-11-01), Elsberry et al.
patent: 6004565 (1999-12-01), Chiba et al.
patent: 6042579 (2000-03-01), Elsberry et al.
patent: 6380177 (2002-04-01), Erickson
patent: 6420339 (2002-07-01), Gegg et al.
patent: 6476004 (2002-11-01), Sakai et al.
patent: 6552170 (2003-04-01), Thompson et al.
patent: 2003/0165485 (2003-09-01), Bertilsson et al.
patent: 2003/0203844 (2003-10-01), Delfani et al.
patent: 2004/0014662 (2004-01-01), Lindquist et al.
patent: 2004/0038888 (2004-02-01), Mercer et al.
patent: 2004/0048377 (2004-03-01), Ericson
patent: 2005/0090520 (2005-04-01), Lindquist
patent: 0812588 (1997-12-01), None
patent: WO 94/08943 (1994-04-01), None
patent: WO 99/19513 (1999-04-01), None
patent: WO 99/36065 (1999-07-01), None
patent: WO 00/09139 (2000-02-01), None
patent: WO 03/094965 (2003-11-01), None
patent: WO 2004/028521 (2004-04-01), None
patent: WO 2005/002559 (2005-01-01), None
patent: WO 2005/025553 (2005-03-01), None
Chun et al. (2002) Pharmacological Reviews 54: 265-269.
Harada et al. (2001). Society for Neuroscience Abstracts 27: 933. Database Biosis, Accession No. PREV200100498277.
Nam et al. (2001). Society for Neuroscience Abstracts 2.—77: 1235. Database Biosis, Accession No. PREV200100549552.
Yoshida and Ueda (2001). Jpn. J. Pharmacol. 87: 104-109.
Colucci-D'Amato and Di Porzio (BioEssays 30:135-145, 2008).
Adachi et al., “Design, synthesis and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720.” Bioorganic and Medicinal Chemistry Letters 5(8): 853-856 (1995).
Altman and Das, “Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats.” J Comp Neurol 124: 319-335 (1965).
Altman and Das, “Postnatal neurogenesis in the guinea-pig.” Nature 214: 1098-1101 (1967).
An et al., “Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids.” FEBS Lett. 417(3):279-82 (1997).
An et al., “Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.” J Biol Chem. 273(14):7906-10. (1998).
An et al., “Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5.” J Biol Chem. 275(1):288-96 (2000).
Anliker and Chun, Lysophospholipid G protein-coupled receptors. J Biol Chem. 279(20): 20555-8 (2004).
Aoki et al., “A novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid with unsaturated fatty-acid moiety.” Ann N Y Acad Sci. 905:263-6 (2000).
Ballmaier M et al., “ Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. ” Eur J Neurosci 15: 1197-205 (2002).
Bayer S.A., “Neurogenesis in the rat primary olfactory cortex.” Int J Dev Neurosci. 4(3):251-71 (1986).
Beer et al., “EDG receptors as a therapeutic target in the nervous system.” Ann N Y Acad Sci. 905: 118-31 (2000).
Bernier et al., “Newly generated neurons in the amygdala and adjoining cortex of adult primates.”Proc Natl Acad Sci U S A. 99(17):11464-9 (2002).
Biebl et al., “Analysis of neurogenesis and programmed cell death reveals a self- renewing capacity in the adult rat brain.” Neurosci Lett 291(1): 17-20 (2000).
Billinton et al., “GABA(B(1)) splice variant mRNAs are differentially affected by electroshock induced seizure in rats.” Neuroreport 11(17):3817-22 (2000).
Björklund and Lindvall, “Cell replacement therapies for central nervous system disorders.” Nat Neurosci. 3(6):537-44 (2000).
Borison and Diamond, “A new animal model for schizophrenia: interactions with adrenergic mechanisms.” Biol Psychiatry 13(2):217-25 (1978).
Born et al.,“Sniffing neuropeptides: a transnasal approach to the human brain.” Nat Neurosci 5(6): 514-6 (2002).
Brinkmann et al, “FTY720: altered lymphocyte traffic results in allograft protection.” Transplantation. 72(5):764-9 (2001).
Brinkmann et al, “The immune modulator FTY720 targets sphingosine 1-phosphate receptors.” J Biol Chem. 277(24): 21453-7 (2002).
Broekkamp et al., “Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice.” Eur J Pharmacol 126(3):223-9 (1986).
Chae et al., “Constitutive expression of the S1P1 receptor in adult tissues.” Prostaglandins Other Lipid Mediat. 73, 141-50 (2004).
Chen et al., “Free thoracodorsal artery perforator flap in extremity reconstruction: 12 cases.” Br J Plast Surg. 57, 525-30 (2004).
Chiba et al., “FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.” Transplant Proc. 31, 1230-3 (1999).
Chun, “Lysophospholipid receptors: implications for neural signaling.” Crit Rev Neurobiol. 13, 151-68 (1999).
Chun et al., “International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.” Pharmacol Rev. 54(2):265-9. (2002).
Colthorpe et al., “The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit.” Pharm Res. Jun; 9(6):764-8 (1992).
Colucci-D'Amato and di Porzio, “Neurogenesis in adult CNS: from denial to opportunities and challenges for therapy.” Bioessays. 30(2):135-45 (2008).
Contos et al., “Requirement for the 1pA1 lysophosphatidic acid receptor gene in normal suckling behavior.” Proc Natl Acad Sci U S A. 97(24):13384-9 (2000).
Craig et al., “In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain.” J Neurosci 16(8): 2649-58 (1996).
Crouch et al., “The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.” J Immunol Methods. 160, 81-8 (1993).
Czlonkowska et al., “Immune processes in the pathogenesis of Parkinson's disease—a potential role for microglia and nitric oxide.” Med Sci Monit. 8(8): RA165-77 (2002).
Doetsch et al., “Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain.” J Neurosci. 17(13):5046-61 (1997).
Doetsch et al., “Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.” Cell 97(6): 703-16 (1999).
Edsall et al., “Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation.” J. Neurosci 17(18): 6952-6960 (1997).
Ekdahl et al., “Inflammation is detrimental for neurogenesis in adult brain.” Proc Natl Acad Sci U S A. 100(23): 13632-7 (2003).
Elliott et al., “Parenteral absorption of insulin from the lung in diabetic children.” Aust Paediatr J 23,293-297 (1987).
Fiore M et al., “Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophr
Lindquist Per
Mercer Alex
Rönnholm Harriet
Wikström Lilian
Elrifi Ivor R.
Gamett Daniel C
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
NeuroNova AB
Nickol Gary B.
LandOfFree
Modulation of neural stem cells and neural progenitor cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of neural stem cells and neural progenitor cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of neural stem cells and neural progenitor cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217183